Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.022 | 0.7 |